Metformin Ipca

Active Ingredient:: Metformin
Origin:: EU

Metformin Ipca (Metformin)

Q: What is Metformin Ipca used for?

Metformin Ipca is used to improve blood‑sugar control in adults with type 2 diabetes mellitus. It may also be employed in prediabetes to delay progression to diabetes and, off‑label, in polycystic ovary syndrome to address insulin resistance.

Q: How does Metformin work?

Metformin reduces hepatic glucose production and increases peripheral insulin sensitivity by inhibiting mitochondrial complex I and activating AMP‑activated protein kinase (AMPK). These actions lower circulating glucose without stimulating insulin release.

Q: What is the usual dose of Metformin Ipca?

The dose of Metformin Ipca is individualized by the prescribing clinician based on the patient’s renal function, glycemic targets, and tolerability. Dosage adjustments are made according to clinical response and safety considerations.

Q: Is Metformin Ipca safe during pregnancy or breastfeeding?

Safety data for Metformin Ipca in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies the potential risk to the fetus or infant, and decisions are made by the treating physician.

Q: How do I order Metformin Ipca from GNH India?

To order Metformin Ipca, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Q: How does Metformin compare with other antidiabetic drugs?

Metformin is a first‑line biguanide that lowers glucose without causing weight gain, unlike some sulfonylureas or insulin. It has a low risk of hypoglycemia when used alone, but may be combined with other agents for additional control. Its cardiovascular safety profile is favorable compared with many older agents.

Q: What are the recommended storage conditions for Metformin Ipca?

Metformin Ipca should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not store in the bathroom or other humid areas.

Q: How is Metformin Ipca administered?

Metformin Ipca is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Q: What are the most serious risks to watch for with Metformin Ipca?

The most serious risk is lactic acidosis, a rare but potentially fatal condition characterized by rapid breathing, muscle pain, abdominal discomfort, and feeling cold. Patients should seek immediate medical attention if these symptoms occur, especially after surgery, contrast imaging, or severe illness.

Q: Who should not use Metformin Ipca?

Metformin Ipca is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in those who have experienced lactic acidosis while on metformin.

Metformin, the active ingredient in Metformin Ipca, is a biguanide presented as an oral tablet for oral use. It is indicated for adults with type 2 diabetes mellitus, where it lowers elevated blood glucose by improving peripheral insulin sensitivity and decreasing hepatic glucose production. The formulation meets European Union quality specifications and is manufactured under GMP conditions.

GNH India supplies Metformin Ipca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ipca Productos Farmaceuticos Unipessoal Lda

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Ipca is a biguanide antidiabetic agent used to manage disorders of glucose metabolism.

Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose.
Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes when combined with lifestyle measures.
Polycystic ovary syndrome: may improve insulin resistance and restore ovulatory function in affected women.

How It Works

Metformin primarily inhibits mitochondrial respiratory‑chain complex I, reducing hepatic gluconeogenesis. It activates AMP‑activated protein kinase (AMPK), which enhances peripheral glucose uptake and fatty‑acid oxidation while decreasing lipogenesis. These metabolic actions lower circulating glucose without stimulating insulin secretion, often resulting in modest weight loss and improved lipid profiles.

Side Effects

Metformin may cause a range of adverse reactions, most of which are related to the gastrointestinal tract, while rare events can be serious.

Common Side Effects

Nausea: transient feeling of sickness, often early in therapy.
Diarrhea: loose stools that may be mild to moderate.
Abdominal discomfort: cramping or pain in the stomach area.
Metallic taste: a transient metallic sensation in the mouth.
Loss of appetite: reduced desire to eat.
Vitamin B12 deficiency: decreased absorption leading to low B12 levels over long‑term use.

Serious or Rare Side Effects

Lactic acidosis: a rare but life‑threatening buildup of lactate.
Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
Hepatotoxicity: liver injury presenting with jaundice or elevated enzymes.
Hypoglycemia: when combined with other glucose‑lowering agents.

Precautions & Warnings

Before initiating Metformin Ipca, several safety considerations should be reviewed.

Renal function: assess eGFR; avoid if eGFR <30 mL/min/1.73 m².
Hepatic function: use with caution in patients with liver disease.
Lactic acidosis risk: discontinue before radiologic contrast studies or major surgery.
Alcohol intake: limit consumption to reduce acidosis risk.
Concomitant medications: review for drugs that may increase metformin levels.
Pregnancy and lactation: safety not established; weigh benefits against risks.
Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Avoid Interactions

Metformin Ipca can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

Iodinated contrast agents: may precipitate lactic acidosis; withhold metformin before and after imaging.
Cimetidine: can increase metformin plasma concentrations.
Nifedipine: may raise metformin levels, increasing toxicity risk.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycemia symptoms.
ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment.
Other antidiabetic agents (sulfonylureas, insulin): increase risk of hypoglycemia.
Thyroid hormones: may alter glucose metabolism.
Diuretics (especially thiazides): can raise blood glucose, necessitating monitoring.

Frequently Asked Questions

Metformin Ipca is used to improve blood‑sugar control in adults with type 2 diabetes mellitus. It may also be employed in prediabetes to delay progression to diabetes and, off‑label, in polycystic ovary syndrome to address insulin resistance.

Metformin reduces hepatic glucose production and increases peripheral insulin sensitivity by inhibiting mitochondrial complex I and activating AMP‑activated protein kinase (AMPK). These actions lower circulating glucose without stimulating insulin release.

The dose of Metformin Ipca is individualized by the prescribing clinician based on the patient’s renal function, glycemic targets, and tolerability. Dosage adjustments are made according to clinical response and safety considerations.

Safety data for Metformin Ipca in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies the potential risk to the fetus or infant, and decisions are made by the treating physician.

To order Metformin Ipca, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Metformin is a first‑line biguanide that lowers glucose without causing weight gain, unlike some sulfonylureas or insulin. It has a low risk of hypoglycemia when used alone, but may be combined with other agents for additional control. Its cardiovascular safety profile is favorable compared with many older agents.

Metformin Ipca should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not store in the bathroom or other humid areas.

Metformin Ipca is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition characterized by rapid breathing, muscle pain, abdominal discomfort, and feeling cold. Patients should seek immediate medical attention if these symptoms occur, especially after surgery, contrast imaging, or severe illness.

Metformin Ipca is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in those who have experienced lactic acidosis while on metformin.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.